Isoindolinone compounds | Patent Number 11912682

US 11912682 B2
Application Number18349634
Publication NumberUS 20230348418 A1
Pendency7 months, 22 days
Filled DateJul 10, 2023
Priority DateNov 18, 2021
Publication DateNov 2, 2023
Expiration DateNov 17, 2041
Inventor/ApplicantsThomas Ryckmans
Alexander Flohr
Bernhard Fasching
ExaminesHABTE, KAHSAY
Art Unit1624
Technology Center1600
Assignments
Monte Rosa Therapeutics Inc.
Current
Monte Rosa Therapeutics Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.